Safety and efficacy of restarting immune checkpoint inhibitors after immune-related adverse events
Immune checkpoint inhibitors can cause a number of immune-related adverse [...]
Liquid biopsies for kidney cancer
New research from the Medical University of Graz in Austria [...]
Promising activity of pembrolizumab plus bevacizumab for metastatic kidney cancer
Results from a phase Ib/II study published in Journal of [...]
Coronavirus: Where to go for advice
Most people will already know about the worldwide coronavirus outbreak, [...]
Research suggests that B cells also play a role in the response to immunotherapy
A recent paper published in the journal Nature earlier this [...]
ASCO GU 2020: VEGF tyrosine kinase inhibitors as second-line treatment after immunotherapy for advanced kidney cancer
A retrospective analysis of data from the International Metastatic Renal [...]
Female kidney cancer patients undergoing surgery for non-metastatic disease may have more favourable prognosis
A retrospective analysis of over 2000 patients from the International [...]
Evaluation of brain metastases in patients with kidney cancer treated with avelumab plus axitinib
In this video interview from Practice Update, Dr Eric Jonasch [...]
ASCO GU 2020: Nephrectomy linked to longer overall survival in patients treated with immunotherapy or targeted therapy for advanced kidney cancer
Surgery to remove the kidney tumour is often the preferred [...]
Novel HIF-2a inhibitor for patients with advanced kidney cancer
In this interview with Practice Update, Dr Eric Jonasch from [...]
